AbbVie to Buy Pharmacyclics in $21 Billion Deal
Post# of 30028
Posted On: 03/05/2015 12:29:08 AM
AbbVie to Buy Pharmacyclics in $21 Billion Deal
For Pharmacyclics, a takeover would culminate a topsy-turvy history. It bought the molecule that became Imbruvica during a fire sale by gene-sequencing company Celera Genomics in 2006.
http://www.wsj.com/articles/abbvie-to-buy-pha...1425528086
http://files.shareholder.com/downloads/PCYC/0...eneral.pdf
Yes I know, this is neither the AbbVie board nor is it the Pharmacyclis board. I believe there has been plenty of connections to PCYC that this wouldn't be entirety OT.
Sometimes the song pays off.
Cheers
For Pharmacyclics, a takeover would culminate a topsy-turvy history. It bought the molecule that became Imbruvica during a fire sale by gene-sequencing company Celera Genomics in 2006.
http://www.wsj.com/articles/abbvie-to-buy-pha...1425528086
http://files.shareholder.com/downloads/PCYC/0...eneral.pdf
Yes I know, this is neither the AbbVie board nor is it the Pharmacyclis board. I believe there has been plenty of connections to PCYC that this wouldn't be entirety OT.
Sometimes the song pays off.
Cheers
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼